Leufkens HGM - Search Results

1

Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple Stakeholders.

Mulder J, Verjans R, Verbaanderd C, Pean E, Weemers J, Leufkens HGM, Pignatti F, de Boer A, Voest EE, Stoyanova-Beninska VV, Pasmooij AMG. Mulder J, et al. Among authors: leufkens hgm. Front Med (Lausanne). 2021 Dec 9;8:790782. doi: 10.3389/fmed.2021.790782. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34957158 Free PMC article.

2

Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme.

Herings RM, de Boer A, Stricker BH, Leufkens HG, Porsius A. Herings RM, et al. Lancet. 1995 May 13;345(8959):1195-8. doi: 10.1016/s0140-6736(95)91988-0. Lancet. 1995. PMID: 7739305

3

The association between antihypertensive drug therapies and plasma lipid levels in the general population.

Maitland-van der Zee AH, Klungel OH, Kloosterman JM, Seidell JC, Leufkens HG, de Boer A. Maitland-van der Zee AH, et al. J Hum Hypertens. 2001 Oct;15(10):701-5. doi: 10.1038/sj.jhh.1001197. J Hum Hypertens. 2001. PMID: 11607800 Clinical Trial.

4

Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma.

Eichler HG, Pignatti F, Flamion B, Leufkens H, Breckenridge A. Eichler HG, et al. Nat Rev Drug Discov. 2008 Oct;7(10):818-26. doi: 10.1038/nrd2664. Epub 2008 Sep 12. Nat Rev Drug Discov. 2008. PMID: 18787530 Review.

5

Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study.

Lalmohamed A, Bazelier MT, Van Staa TP, Uitdehaag BM, Leufkens HG, De Boer A, De Vries F. Lalmohamed A, et al. Eur J Neurol. 2012 Jul;19(7):1007-14. doi: 10.1111/j.1468-1331.2012.03668.x. Epub 2012 Feb 21. Eur J Neurol. 2012. PMID: 22353360

6

Fracture rate in patients with myasthenia gravis: the general practice research database.

Pouwels S, de Boer A, Javaid MK, Hilton-Jones D, Verschuuren J, Cooper C, Leufkens HG, de Vries F. Pouwels S, et al. Osteoporos Int. 2013 Feb;24(2):467-76. doi: 10.1007/s00198-012-1970-5. Epub 2012 Apr 25. Osteoporos Int. 2013. PMID: 22531999 Free PMC article.

7

Prolonged outpatient vitamin K antagonist use and risk of venous thromboembolism in patients undergoing total hip or knee replacement.

Lalmohamed A, Vestergaard P, Jansen PA, Grove EL, de Boer A, Leufkens HG, van Staa TP, de Vries F. Lalmohamed A, et al. J Thromb Haemost. 2013 Apr;11(4):642-50. doi: 10.1111/jth.12158. J Thromb Haemost. 2013. PMID: 23387806 Free article.

8

Risk of fracture in patients with muscular dystrophies.

Pouwels S, de Boer A, Leufkens HG, Weber WE, Cooper C, van Onzenoort HA, de Vries F. Pouwels S, et al. Osteoporos Int. 2014 Feb;25(2):509-18. doi: 10.1007/s00198-013-2442-2. Epub 2013 Aug 15. Osteoporos Int. 2014. PMID: 23948807

9

Selection of oncology medicines in low- and middle-income countries.

Bazargani YT, de Boer A, Schellens JH, Leufkens HG, Mantel-Teeuwisse AK. Bazargani YT, et al. Ann Oncol. 2014 Jan;25(1):270-6. doi: 10.1093/annonc/mdt514. Ann Oncol. 2014. PMID: 24356638 Free article.

10

Essential medicines are more available than other medicines around the globe.

Bazargani YT, Ewen M, de Boer A, Leufkens HG, Mantel-Teeuwisse AK. Bazargani YT, et al. PLoS One. 2014 Feb 12;9(2):e87576. doi: 10.1371/journal.pone.0087576. eCollection 2014. PLoS One. 2014. PMID: 24533058 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

542 results

Search Page

Filters